Abstract
Inherited kidney diseases are not rare. The main groups are listed in Table 1. All nephrologists are exposed to patients and families with inherited disorders who are seeking diagnosis and counseling. In adults, hereditary renal diseases represent approximately 10%–12% of the causes of end-stage renal disease (ESRD) in most countries, whereas they represent 20%–30% of the causes of ESRD in children. These figures, however, do not reflect the whole clinical scope of inherited kidney disorders, many of which do not progress to ESRD or do not progress in all affected members of an affected family. Thus, many more affected (and unaffected) subjects may require genetic counseling. All nephrologists need some skill in genetics. Much remains to be done in educating physicians and families in genetics (1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Harris R: How well do we manage families with genetic problems? Br Med J 303: 1412–1413, 1991.
Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney diseases. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161–1165, 1989.
Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET: X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325: 681–686, 1991.
Bilous RW, Murty G, Parkinson DB, Thakker RV, Coulthard MG, Burn J, Mathias D, Kendall-Taylor P: Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness and renal dysplasia. N Engl J Med 327: 1069–1074, 1992.
Knebelmann B, Antignac C, Gubler MC, Grtinfeld JP: A molecular approach to inherited kidney disorders. Kidney Im 44: 1205–1216, 1993.
Bakker E, Van Broeckhoven C, Bonten EJ, van de Vooren MJ, Veenema H, Van Hul W, Van Ommen GJ, Vandenberghe A, Pearson PL: Germline mosaicism and Duchenne muscular dystrophy mutations. Nature 329: 554556, 1987.
Attree O, Olivos I, Okabe I, Bailey LC, Nelson DL, Lewis RA, McInnes RR, Nussbaum RL: The Lowe’s oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 358: 239–242, 1992.
The European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77: 88 1894, 1994.
Danpure CJ: Molecular and clinical heterogeneity in primary hyperoxaluria type I. Am J Kidney Dis 17: 366–369, 1991.
Pirson Y, Grünfeld JP: Autosomal-dominant polycystic kidney disease. In: JS Cameron, AM Davison, JP Grünfeld, DNS Kerr, E Ritz, eds, Oxford Textbook of Clinical Nephrology, Oxford University Press, Oxford, pp 2171–2188, 1992.
Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343: 824–827, 1994.
Kashtan CE, Michael AF: Alport syndrome: from bedside to genome to bedside. Am J Kidney Dis 22: 627–640, 1993.
Chelly J, Concordet JP, Kaplan JC, Kahn A: Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 86: 2617–2621, 1989.
Motulsky AG: Societal problems in human and medical genetics. Genome 31: 870–875, 1989.
Ryynanen M, Dolata MM, Lampainen E, Reeders ST: Localisation of a mutation producing autosomal dominant polycystic kidney disease without renal failure. J Med Genet 24: 462–465, 1987.
Gretz N, Zeier M, Geberth S, Strauch M, Ritz E: Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis 14: 178–183, 1989.
Lindheimer MD, Davison JM eds: Renal Disease in Pregnancy (Baillière’s Clinical Obstetrics and Gynaecology, vol. 8, No. 2.) Baillière Tindall, London, p 532, 1994.
Jungers P, Forget D, Henry-Amar M, Albouze G, Fournier P, Vischer U, Droz D, Noël LH, Grünfeld JP: Chronic kidney disease and pregnancy. Adv Nephrol 15: 103–141, 1986.
Barron WM, Lindheimer MD: Medical Disorders during Pregnancy,2nd ed. Mosby Year Book, St. Louis, in press.
Gabow PA, Johnson AM, Kaehny WD: Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11:1033–1037, 1990.
Chapman AB, Rubinstein D, Hughes R, et al.: Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 327: 916–920, 1992.
Wiebers DO, Torres VE: Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 327: 953–995, 1992.
Grünfeld JP: Alport’s syndrome. In: JS Cameron, AM Davison, JP Grünfeld, D Kerr, E Ritz, eds, Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford, pp 2197–2205, 1992.
Bailey RR: Vesicoureteric reflux and reflux nephropathy. In: JS Cameron, AM Davison, JR Grünfeld, D Kerr, E Ritz eds, Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford, pp 1983–2001, 1992.
Torres VE, King BF, Holley KE, Blute ML, Gomez MR: The kidney in the tuberous sclerosis complex. Adv Nephrol 23: 43–90, 1994.
Neumann HPH Zbar B: Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int 51: 16–26, 1997.
Pras E, Aksentijevich I, Gruberg L, Balow JE Jr, Prosen L, Dean M, Steinberg AD, Pras M, Kastner DL: Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 326: 1509 1513.
Zemer D, Livneh A, Danon YL, Pras M, Sohar E: Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 34: 973–977, 1991.
Livneh A, Cabili S, Zemer D, Rabinovitch O, Pras M: Effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. J Rheum 20: 1519–1523, 1993.
Harper PS: Insurance and genetic testing. Lancet 341: 224–227, 1993.
Wulfsberg EA, Hoffman DE, Cohen MM: Impact of genetic discovery on medicine and society. JAMA 271: 217–222, 1994.
National Kidney Foundation Scientific Advisory Board: Gene testing in autosomal dominant polycystic kidney disease: results of National Kidney Foundation workshop. Am J Kidney Dis 13: 85–87, 1989.
Danpure CJ, Jennings PR, Penketh RJ, Wise PJ, Rodeck CH: Prenatal exclusion of primary hyperoxaluria type I. Lancet i: 367, 1988.
Sujansky E, Kreutzer SB, Johnson AM, Lezotte DC, Schrier RW, Gabow PA: Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. Am J Med Genet 35: 510–515, 1990.
Lipshitz A, Weinstein T, Zein D, Gafter U, Ori Y, Levi J: Genetic counseling in adult polycystic kidney disease in Israel. Nephron 55: 386–388, 1990.
Lévy M, Pirson Y, Simon P, Boudailliez B, Nivet H, Rancé N, Moynot A, Broyer M, Grünfeld JP: Evaluation in patients with Alpost syndrome of knowledge of the disease and attitudes toward prenatal diagnosis. Clin Nephrol 42: 211–220, 1994.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Grünfeld, JP., Choukroun, G., Knebelmann, B. (1998). Genetic Diagnosis and Counseling in Inherited Renal Diseases. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_41
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6632-5_41
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6634-9
Online ISBN: 978-1-4757-6632-5
eBook Packages: Springer Book Archive